Key HighlightsThryv Holdings (NASDAQ:THRY) reported a third-quarter 2026 net loss of USD 116.0 million, or USD 2.61 per diluted share, on November 9, including a USD 94.8 million non-cashGoodwillimpairment.ConsolidatedRevenuefell 13.5% to USD 118.9 million from USD 137.4 million and missed forecasts, as the print …
Key HighlightsUSA Rare Earth (NASDAQ:USAR) reported third-quarter 2026Revenueof USD 3.0 million on November 9, its first full quarter of commercial magnet sales, against no revenue a year earlier.The Serra Verde project in Brazil made its first commercial-scale shipments of mixed rare earth concentrate in …
Key HighlightsRepay Holdings (NASDAQ:RPAY) lowered its 2026 normalized organic growth outlook to 5% to 6% from 7% to 9% on November 9, 2026, excluding political media.Third-quarterRevenuerose 97% to USD 153.4 million, but KUBRA, acquired on June 1, 2026, contributed USD 65.1 million of that …
In chronic autoimmune diseases such as myasthenia gravis, patients may need treatment for years. A drug given every eight weeks under the skin, rather than weekly infusions or injections, would be a clear convenience advantage and could support adoption if efficacy is comparable. The …
Roivant's majority-owned Immunovant unit reported that a 600 milligram dose of IMVT-1402, an FcRn inhibitor, met the primary endpoint in a potentially registrational study in difficult-to-treat rheumatoid arthritis. At week 28, 92.5% of patients on that dose achieved an ACR20 response against 75.6% on …
The promotion is small in financial terms, but it speaks to a bigger issue. Comcast's broadbandBusinesshas faced intense competition from fixed wireless services offered by mobile carriers and from fiber builders, and the company has been working to slow customer losses. Free upgrades for …
Tripadvisor reported third-quarter 2026 revenue of USD 436.4 million against about USD 453.2 million expected, and adjusted earnings of USD 0.37 per share against USD 0.45. Weakness was concentrated in the Hotels and Other segment, where search-driven traffic has come under pressure from changes …
The third quarter gave the thesis some support. Revenue beat consensus for the twelfth quarter in a row, and adjusted EBITDA was positive at USD 0.3 million. That matters because the fourth quarter is seasonally the strongest for elective surgery, as patients use remaining …
Key HighlightsKaryopharm Therapeutics (NASDAQ:KPTI) is down 22.25% at USD 0.0311 after a Chapter 11 filing on November 2, 2026, aNasdaqdelisting notice and a plan that gives common stockholders no payment.Wellchange (NASDAQ:WCT) is down 22.15% at USD 3.48 from a calculated USD 4.47, the second …
Key HighlightsEdesa Biotech (NASDAQ:EDSA) shares rose 38.63%, or USD 0.83, to USD 2.97 on November 9, 2026 after the company licensed its ARDS drug candidate in Japan to Kyorin Pharmaceutical.Edesa receives USD 12 million upfront and is eligible for up to about USD 134 …